Bioharvest Sciences (BHST) Net Income towards Common Stockholders (2023 - 2025)

Bioharvest Sciences' Net Income towards Common Stockholders history runs 3 years deep, the most recent figure standing at -$2.1 million for Q4 2025.

• In Q4 2025, Net Income towards Common Stockholders rose 30.39% year-over-year to -$2.1 million; the TTM figure through Dec 2025 stood at -$11.0 million (up 14.89% YoY), while the FY2025 annual figure was -$11.0 million, up 14.84% from the prior year.
• Net Income towards Common Stockholders was -$2.1 million for Q4 2025 at Bioharvest Sciences, up from -$2.5 million in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of $7.2 million in Q4 2023 to a low of -$6.6 million in Q1 2024.
• Historically, Net Income towards Common Stockholders has averaged -$1.1 million across 3 years, with a median of -$2.3 million in 2025.
• Biggest YoY gain for Net Income towards Common Stockholders was 64.47% in 2025; the steepest drop was 493.89% in 2025.
• A 3-year view of Net Income towards Common Stockholders shows it stood at $7.2 million in 2023, then slumped by 140.75% to -$2.9 million in 2024, then surged by 30.39% to -$2.1 million in 2025.
• The last three Net Income towards Common Stockholders figures came in at -$2.1 million (Q4 2025), -$2.5 million (Q3 2025), and -$4.1 million (Q2 2025), per Business Quant data.